FDA Defends Its Handling of Vioxx Safety (AP) AP - Amid questions about whether the arthritis drug Vioxx was taken off the market soon enough, a key senator suggested Friday that an independent board of drug safety might be needed to ensure the safety of medications after they're approved for the market.